Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
暂无分享,去创建一个
[1] P. Turchetti,et al. Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience. , 2020, La Clinica terapeutica.
[2] P. McCluskey,et al. Intravitreal dexamethasone implants for non‐infectious uveitis , 2019, Clinical & experimental ophthalmology.
[3] L. Kodjikian,et al. Pro Re Nata Dexamethasone Implant for Treatment-Naive Phakic Eyes with Diabetic Macular Edema: A Prospective Study. , 2019, Ophthalmology. Retina.
[4] B. Prum,et al. Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes , 2019, Journal of glaucoma.
[5] S. Sivaprasad,et al. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study. , 2019, Ophthalmology.
[6] Z. Aktaş,et al. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis , 2019, Turkish journal of ophthalmology.
[7] J. Chhablani,et al. Safety of 6000 intravitreal dexamethasone implants , 2019, British Journal of Ophthalmology.
[8] R. Tadayoni,et al. Efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study , 2019, Journal of current ophthalmology.
[9] V. Castro-Navarro,et al. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema , 2019, BMC Ophthalmology.
[10] J. Chhablani,et al. DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study , 2019, Retina.
[11] C. Kim,et al. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients , 2018, British Journal of Ophthalmology.
[12] M. Maia,et al. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience , 2018, Ophthalmologica.
[13] A. Stavrakakis,et al. Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema , 2018, Eye.
[14] A. Mansour,et al. Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant , 2018, British Journal of Ophthalmology.
[15] A. Capone,et al. Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study. , 2018, Ophthalmic surgery, lasers & imaging retina.
[16] Sepehr Bahadorani,et al. The effects of repeated Ozurdex injections on ocular hypertension , 2018, Clinical ophthalmology.
[17] D. Pohlmann,et al. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience. , 2018, Ophthalmology.
[18] Altan Göktaş,et al. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion , 2016, Seminars in ophthalmology.
[19] P. Tien,et al. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series. , 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[20] Ningli Wang,et al. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.
[21] Dorukcan Akıncıoğlu,et al. Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema , 2017, Turkish journal of ophthalmology.
[22] James D. Palmer,et al. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS , 2017, Retina.
[23] N. Voirin,et al. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension , 2017, Retina.
[24] N. Voirin,et al. REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT: The Reldex Study , 2017, Retina.
[25] M. Varano,et al. INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY , 2016, Retina.
[26] A. Heiligenhaus,et al. [Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis]. , 2016, Klinische Monatsblatter fur Augenheilkunde.
[27] R. Iezzi,et al. EVALUATION OF MULTIPLE DEXAMETHASONE INTRAVITREAL IMPLANTS IN PATIENTS WITH MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION , 2016, Retina.
[28] R. Gallemore,et al. Strong topical steroid, NSAID, and carbonic anhydrase inhibitor cocktail for treatment of cystoid macular edema , 2015, International medical case reports journal.
[29] A. Loewenstein,et al. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study , 2015, BMC Ophthalmology.
[30] A. Dick,et al. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. , 2014, American journal of ophthalmology.
[31] J. Garcia-Arumi,et al. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema. , 2014, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[32] S. Whitcup,et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.
[33] D. Roth,et al. EFFICACY AND SAFETY OF TWO OR MORE DEXAMETHASONE INTRAVITREAL IMPLANT INJECTIONS FOR TREATMENT OF MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION (SHASTA STUDY) , 2014, Retina.
[34] C. Meyer,et al. [Reliability and safety of intravitreal Ozurdex injections. The ZERO study]. , 2014, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[35] M. Mesquida,et al. DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF UVEITIC PERSISTENT CYSTOID MACULAR EDEMA IN VITRECTOMIZED PATIENTS , 2013, Retina.
[36] K. Schmitz,et al. Zuverlässigkeit und Sicherheit von intravitrealen Ozurdex-Injektionen , 2013, Der Ophthalmologe.
[37] M. Blumenkranz,et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. , 2011, Ophthalmology.
[38] M. Blumenkranz,et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.